Sorrento Therapeutics Inc: Company Profile & Overview, History, Stock Price & News
Sorrento Therapeutics is a famous public-owned company that works to deliver treatments mainly for cancer patients. It was founded in the year 2006 in California.
Sorrento Therapeutics-Introduction: Sorrento Therapeutics runs with a vision to produce such antibodies which will help cancer patients to a large extent making the whole treatment process much easier. The company has also partnered with several other pharmaceutical companies so that they can reach those families who are dealing with such diseases. The medical facilities that are provided by the company will help the patients to get a better quality of life. Later on, the company also started to work for none opioid treatments and Covid 19.
The Sorrento Therapeutics company constantly working toward making it easy for cancer patients to get rid of the disease easily.
History of Sorrento Therapeutics
The Sorrento Therapeutics company started with a humble thought to develop something that would change the lives of people. The primary objective of the company was only to cater to the needs of cancer patients but with time and experience, the company started to explore other fields or went on to further cure people dealing with autoimmune diseases and other chronic diseases.
Read Also~University: Meaning, Definition, Origin, History & Interesting Facts
The price history of Sorrento Therapeutics
At the beginning of the year, the company was giving it to its investors when the price of the stick rose by almost 31% along with the market capitalization of almost $ 2.5 billion. However, during the pandemic period when other companies like Pfizer and Moderna got the approvals for the covid 19 vaccine, the price of the Sorrento Therapeutics share crashed.
The market price in July 2022
As of 29 July 2022, the Sorrento Therapeutics share price is $2.62 per share. At the time of its Initial Public offerings that are in the year 2015, the company announced the offering of 4,150,000 shares of common Sorrento Therapeutics share price of $7.25 per share which was a nice deal for the investors at that time.
Read Also~Tata Sky History & Overview-Best DTH (Direct To Home) Service Provider in India
Is this a good investment for a long period?
As of the year 2022, the Sorrento Therapeutics company is working at its best but the price of the stocks is only falling which is a bad thing for the investors. Investing in the company shares might not be a very wise decision at this time and it is difficult for the company at this point to return to a good position in the stock market. To conclude, it can be said that it is a very risky investment.